More pain in Q3

$10x Genomics(TXG.US)$ Not everthing is positive with this stock. I can see more pain and it will test to $10 by the end of Q3. Management is try, hope they will fix it. For long term I am positive and invest if it will show sign of reversal. Fundamental is nutral, but trend and sentiment both are negative for Q3.